Development of broadly neutralizing antibodies targeting the cytomegalovirus subdominant antigen gH

Human cytomegalovirus (HCMV) is a β-herpesvirus that increases morbidity and mortality in immunocompromised individuals including transplant recipients and newborns. New anti-HCMV therapies are an urgent medical need for diverse patient populations. HCMV infection of a broad range of host tissues is...

Descripción completa

Detalles Bibliográficos
Autores principales: Parsons, Andrea J., Ophir, Sabrina I., Duty, J. Andrew, Kraus, Thomas A., Stein, Kathryn R., Moran, Thomas M., Tortorella, Domenico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038728/
https://www.ncbi.nlm.nih.gov/pubmed/35468974
http://dx.doi.org/10.1038/s42003-022-03294-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038728/
https://www.ncbi.nlm.nih.gov/pubmed/35468974
http://dx.doi.org/10.1038/s42003-022-03294-z

Ejemplares similares